Stock Traders Purchase High Volume of Call Options on Allscripts Healthcare Solutions (MDRX)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) saw unusually large options trading on Friday. Stock traders acquired 1,776 call options on the company. This is an increase of approximately 1,694% compared to the average daily volume of 99 call options.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $14.26, for a total transaction of $213,900.00. Following the completion of the sale, the president now directly owns 1,351,773 shares in the company, valued at approximately $19,276,282.98. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP James Hewitt sold 36,796 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the sale, the senior vice president now owns 181,766 shares of the company’s stock, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders sold a total of 56,796 shares of company stock valued at $804,842 in the last ninety days. 0.75% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of MDRX. Bank of Montreal Can grew its position in shares of Allscripts Healthcare Solutions by 6.9% in the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock valued at $135,000 after purchasing an additional 689 shares in the last quarter. Arizona State Retirement System grew its position in Allscripts Healthcare Solutions by 1.9% in the second quarter. Arizona State Retirement System now owns 76,500 shares of the software maker’s stock worth $976,000 after acquiring an additional 1,400 shares during the period. Rhumbline Advisers grew its position in Allscripts Healthcare Solutions by 13.1% in the second quarter. Rhumbline Advisers now owns 380,476 shares of the software maker’s stock worth $4,855,000 after acquiring an additional 44,129 shares during the period. Virginia Retirement Systems ET AL purchased a new position in Allscripts Healthcare Solutions in the second quarter worth approximately $468,000. Finally, Victory Capital Management Inc. grew its position in Allscripts Healthcare Solutions by 6.8% in the second quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock worth $20,763,000 after acquiring an additional 103,395 shares during the period.

MDRX has been the subject of several research reports. Maxim Group reiterated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, November 8th. Robert W. Baird boosted their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, November 3rd. Cantor Fitzgerald reiterated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Wednesday, September 27th. Finally, SunTrust Banks reiterated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $15.06.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $14.55 on Monday. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98. The stock has a market capitalization of $2,628.91, a P/E ratio of -12.54, a PEG ratio of 2.59 and a beta of 1.34. Allscripts Healthcare Solutions has a 52-week low of $10.19 and a 52-week high of $15.20.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2018/01/01/stock-traders-purchase-high-volume-of-call-options-on-allscripts-healthcare-solutions-mdrx.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply